MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Post by Parrotheadon Aug 20, 2020 8:57am

195 Views

Post# 31432558

Good Read Lateral Flow COVID Tests

Read to the bottom, 3rd last paragraph - Specifically, Dr. Gottlieb said that lateral flow tests, which provide a readout on a device like a pregnancy test, could be coming onto the U.S. market soon.

Wait, doesn't MIR use lateral flow technology and it is patented?

https://www.cnbc.com/2020/08/17/dr-scott-gottlieb-touts-yale-new-saliva-based-coronavirus-test.html

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal